Argon Laser Photocoagulation Combined With Subconjunctival and Intravitreal Bevacizumab Injections for a Retrocorneal Neovascular Membrane.
10.3341/jkos.2010.51.2.292
- Author:
Mo Sae KIM
1
;
Joon Mo KIM
;
Chul Young CHOI
Author Information
1. Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. sashimi0@naver.com
- Publication Type:Case Report
- Keywords:
Bevacizumab;
Laser photocoagulation;
Retrocorneal membrane
- MeSH:
Aged;
Antibodies, Monoclonal, Humanized;
Argon;
Cataract Extraction;
Cicatrix;
Cornea;
Eye;
Female;
Humans;
Light Coagulation;
Membranes;
Visual Acuity;
Bevacizumab
- From:Journal of the Korean Ophthalmological Society
2010;51(2):292-296
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report a case of retrocorneal membrane effectively treated with focal argon laser photocoagulation combined with subconjunctival and intravitreal bevacizumab injections. CASE SUMMARY: A 69-year-old female presented with persistent ocular pain and decreased visual acuity of the right eye following a complicated extracapsular cataract extraction performed nine months earliet. On examination, there was a neovascular retrocorneal membrane covering the superior one-third of the cornea with a sutured wound along the limbus. Following unresponsive conservative treatment, we performed focal argon laser photocoagulation followed by subconjunctival and intravitreal bevacizumab injections (1.25 mg). Two weeks later, markedly regressed neovascularization was noted. Additional argon laser photocoagulation, subconjunctival and intravitreal bavacizumab were performed six weeks later. Four months after the last treatment, the neovascular component substantially decreased and fibrous scar tissue replaced the neovascularization. The retrocorneal membrane showed no progression.
